MAA
Mraz Amerine & Associates’s Core Laboratories CLB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-62,205
| Closed | -$1.26M | – | 168 |
|
|
2024
Q2 | $1.26M | Sell |
62,205
-1,257
| -2% | -$25.5K | 0.26% | 68 |
|
|
2024
Q1 | $1.08M | Sell |
63,462
-1,787
| -3% | -$30.5K | 0.2% | 74 |
|
|
2023
Q4 | $1.15M | Sell |
65,249
-1,257
| -2% | -$22.2K | 0.24% | 67 |
|
|
2023
Q3 | $1.6M | Sell |
66,506
-950
| -1% | -$22.8K | 0.36% | 53 |
|
|
2023
Q2 | $1.57M | Sell |
67,456
-18
| -0% | -$419 | 0.37% | 51 |
|
|
2023
Q1 | $1.49M | Sell |
67,474
-305
| -0.4% | -$6.73K | 0.37% | 54 |
|
|
2022
Q4 | $1.37M | Sell |
67,779
-6,242
| -8% | -$127K | 0.32% | 53 |
|
|
2022
Q3 | $998K | Buy |
74,021
+7,502
| +11% | +$101K | 0.27% | 62 |
|
|
2022
Q2 | $1.32M | Sell |
66,519
-666
| -1% | -$13.2K | 0.34% | 53 |
|
|
2022
Q1 | $2.13M | Buy |
67,185
+561
| +0.8% | +$17.7K | 0.51% | 29 |
|
|
2021
Q4 | $1.49M | Buy |
66,624
+32,206
| +94% | +$718K | 0.38% | 47 |
|
|
2021
Q3 | $955K | Buy |
34,418
+8,177
| +31% | +$227K | 0.26% | 69 |
|
|
2021
Q2 | $1.02M | Buy |
26,241
+965
| +4% | +$37.6K | 0.28% | 64 |
|
|
2021
Q1 | $728K | Sell |
25,276
-169
| -0.7% | -$4.87K | 0.21% | 72 |
|
|
2020
Q4 | $675K | Buy |
25,445
+14,965
| +143% | +$397K | 0.22% | 66 |
|
|
2020
Q3 | $160K | Buy |
+10,480
| New | +$160K | 0.06% | 140 |
|
|
2014
Q2 | – | Sell |
-1,100
| Closed | -$218K | – | 146 |
|
|
2014
Q1 | $218K | Hold |
1,100
| – | – | 0.09% | 120 |
|
|
2013
Q4 | $210K | Buy |
+1,100
| New | +$210K | 0.09% | 122 |
|